Page last updated: 2024-11-02

phenobarbital and Spinal Cord Diseases

phenobarbital has been researched along with Spinal Cord Diseases in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Spinal Cord Diseases: Pathologic conditions which feature SPINAL CORD damage or dysfunction, including disorders involving the meninges and perimeningeal spaces surrounding the spinal cord. Traumatic injuries, vascular diseases, infections, and inflammatory/autoimmune processes may affect the spinal cord.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ravakhah, K1
West, BC1

Other Studies

1 other study available for phenobarbital and Spinal Cord Diseases

ArticleYear
Case report: subacute combined degeneration of the spinal cord from folate deficiency.
    The American journal of the medical sciences, 1995, Volume: 310, Issue:5

    Topics: Adult; Erythrocyte Transfusion; Folic Acid; Folic Acid Deficiency; Humans; Male; Phenobarbital; Spin

1995